About This Research Study
Episodic migraine is marked by recurring headaches that occur fewer than 15 days per month and can severely impact daily life. Tekton Research is conducting a clinical study evaluating an investigational injection for migraine prevention in individuals living with episodic migraine.
Eligible participants…
- Must be 18+
- Must have been diagnosed with episodic migraine with or without aura at least 1 year prior to screening
- Must experience 14 or fewer headache days and 6 to 14 migraine days per month for the past 3 months
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.